非洲：共同应对艾滋病毒和新冠疫情。 - Suppr

Suppr

超能文献

Africa: tackle HIV and COVID-19 together.

作者信息

Msomi Nokukhanya, Lessells Richard, Mlisana Koleka, de Oliveira Tulio

出版信息

Nature. 2021 Dec;600(7887):33-36. doi: 10.1038/d41586-021-03546-8.

DOI:10.1038/d41586-021-03546-8

PMID:34853449

Abstract

摘要

相似文献

Africa: tackle HIV and COVID-19 together.非洲：共同应对艾滋病毒和新冠疫情。

Nature. 2021 Dec;600(7887):33-36. doi: 10.1038/d41586-021-03546-8.

Cash payments in Africa could boost vaccine uptake.在非洲进行现金支付可能会提高疫苗接种率。

Nature. 2021 Aug;596(7870):9. doi: 10.1038/d41586-021-02086-5.

HIV and covid-19 in South Africa.南非的艾滋病毒与新冠疫情

BMJ. 2022 Jan 27;376:e069807. doi: 10.1136/bmj-2021-069807.

Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.音频访谈：南非的新冠疫情与一种新型新冠病毒变种

N Engl J Med. 2021 Jan 14;384(2):e14. doi: 10.1056/NEJMe2100736.

COVID-19 and global equity for health: The good, the bad, and the wicked.新冠疫情大流行与全球卫生公平：好、坏、恶。

PLoS Med. 2021 Oct 1;18(10):e1003797. doi: 10.1371/journal.pmed.1003797. eCollection 2021 Oct.

COVID-19 in Africa: between hope and reality.非洲的新冠疫情：希望与现实之间

Lancet Infect Dis. 2021 Mar;21(3):315. doi: 10.1016/S1473-3099(20)30465-5. Epub 2020 Jun 15.

Africa's need for more COVID-19 clinical trials.非洲对更多新冠病毒临床试验的需求。

Lancet. 2021 May 29;397(10289):2037. doi: 10.1016/S0140-6736(21)01198-3.

Africa's vaccines revolution must have research at its core.非洲的疫苗革命必须以研究为核心。

Nature. 2021 Apr;592(7855):487-488. doi: 10.1038/d41586-021-01038-3.

An African plan to control COVID-19 is urgently needed.迫切需要一项控制新冠疫情的非洲计划。

Lancet. 2020 Dec 5;396(10265):1777. doi: 10.1016/S0140-6736(20)32580-0.

How many COVID deaths are acceptable in a post-pandemic world?在疫情后的世界里，多少新冠死亡人数是可以接受的？

Nature. 2021 May;593(7859):326-327. doi: 10.1038/d41586-021-01220-7.

引用本文的文献

Exploring the oncogenic potential of SARS-CoV-2 in the gastrointestinal tract.探索严重急性呼吸综合征冠状病毒2（SARS-CoV-2）在胃肠道中的致癌潜力。

World J Gastroenterol. 2025 Aug 21;31(31):105665. doi: 10.3748/wjg.v31.i31.105665.

National investment case development for pathogen genomics.病原体基因组学的国家投资案例开发

Cell Genom. 2025 Mar 12;5(3):100781. doi: 10.1016/j.xgen.2025.100781. Epub 2025 Feb 27.

Targeting mutation sites in the omicron variant of SARS-CoV-2 as potential therapeutic strategy against COVID-19 by antiretroviral drugs.以严重急性呼吸综合征冠状病毒2（SARS-CoV-2）奥密克戎变异株中的突变位点为靶点，采用抗逆转录病毒药物作为对抗2019冠状病毒病（COVID-19）的潜在治疗策略。

Toxicol Rep. 2024 Nov 22;13:101825. doi: 10.1016/j.toxrep.2024.101825. eCollection 2024 Dec.

Bridging gene therapy and next-generation vaccine technologies.连接基因治疗与下一代疫苗技术。

Gene Ther. 2025 Jan;32(1):4-7. doi: 10.1038/s41434-024-00502-9. Epub 2024 Nov 18.

Adopting sustainable innovations for remote access to TB and HIV care in South Africa.在南非采用可持续创新手段实现结核病和艾滋病护理的远程获取。

PLOS Glob Public Health. 2024 Oct 16;4(10):e0003792. doi: 10.1371/journal.pgph.0003792. eCollection 2024.

Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections.SARS-CoV-2突破性感染后HIV感染者的疫苗反应和混合免疫

NPJ Vaccines. 2024 Oct 9;9(1):185. doi: 10.1038/s41541-024-00972-3.

Spatial, temporal, and demographic nonstationary dynamics of COVID-19 exposure among older adults in the U.S.美国老年人 COVID-19 暴露的时空和人口统计学非平稳动态

PLoS One. 2024 Aug 22;19(8):e0307303. doi: 10.1371/journal.pone.0307303. eCollection 2024.

Impact of COVID-19 on human immunodeficiency virus tests, new diagnoses, and healthcare visits in the Republic of Korea: a retrospective study from 2016 to 2021.新型冠状病毒肺炎对韩国人类免疫缺陷病毒检测、新诊断病例及医疗就诊的影响：一项2016年至2021年的回顾性研究

Osong Public Health Res Perspect. 2024 Aug;15(4):340-352. doi: 10.24171/j.phrp.2024.0123. Epub 2024 Aug 1.

Barriers and Enablers to Retention in HIV Care and Adherence to Antiretroviral Therapy: Evidence from Dar es Salaam, Tanzania.坦桑尼亚达累斯萨拉姆的证据：艾滋病毒护理留存率及抗逆转录病毒疗法依从性的障碍与促进因素

HIV AIDS (Auckl). 2024 Jul 26;16:301-311. doi: 10.2147/HIV.S458545. eCollection 2024.

Managing and assembling population-scale data streams, tools and workflows to plan for future pandemics within the INFORM-Africa Consortium.在“非洲信息行动”（INFORM-Africa）联盟内管理和整合大规模人口数据流、工具及工作流程，以规划应对未来的大流行病。

S Afr J Sci. 2023 May-Jun;119(5-6). doi: 10.17159/sajs.2023/14659. Epub 2023 May 30.

本文引用的文献

Undetected COVID-19 cases in Africa.非洲未被检测出的新冠病例。

Lancet Respir Med. 2021 Dec;9(12):e121. doi: 10.1016/S2213-2600(21)00504-X. Epub 2021 Nov 11.

A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa.一年的基因组监测揭示了 SARS-CoV-2 大流行在非洲的发展情况。

Science. 2021 Oct 22;374(6566):423-431. doi: 10.1126/science.abj4336. Epub 2021 Sep 9.

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial.在南非，针对有和没有 HIV 的人群的 ChAdOx1 nCoV-19（AZD1222）疫苗对 SARS-CoV-2 的安全性和免疫原性：一项随机、双盲、安慰剂对照、1B/2A 期临床试验的中期分析。

Lancet HIV. 2021 Sep;8(9):e568-e580. doi: 10.1016/S2352-3018(21)00157-0. Epub 2021 Aug 17.

Vaccine nationalism and the dynamics and control of SARS-CoV-2.疫苗民族主义与 SARS-CoV-2 的传播和控制

Science. 2021 Sep 24;373(6562):eabj7364. doi: 10.1126/science.abj7364.

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.移植受者中第三剂mRNA-1273疫苗的随机试验。

N Engl J Med. 2021 Sep 23;385(13):1244-1246. doi: 10.1056/NEJMc2111462. Epub 2021 Aug 11.

Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study.南非高 HIV 和结核病流行地区 COVID-19 相关住院死亡率的危险因素：一项队列研究。

Lancet HIV. 2021 Sep;8(9):e554-e567. doi: 10.1016/S2352-3018(21)00151-X. Epub 2021 Aug 4.

SARS-CoV-2 Variants in Patients with Immunosuppression.免疫抑制患者中的新型冠状病毒2型变体

N Engl J Med. 2021 Aug 5;385(6):562-566. doi: 10.1056/NEJMsb2104756.

COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control.COVID-19 和非洲的间接健康影响：影响、缓解措施以及改善疾病控制的经验教训。

PLoS Med. 2021 Jun 23;18(6):e1003666. doi: 10.1371/journal.pmed.1003666. eCollection 2021 Jun.

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.腺病毒载体新冠疫苗（AZD1222）在人类免疫缺陷病毒（HIV）感染者中针对严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）的安全性和免疫原性：一项 2/3 期临床试验的单臂亚研究。

Lancet HIV. 2021 Aug;8(8):e474-e485. doi: 10.1016/S2352-3018(21)00103-X. Epub 2021 Jun 18.

Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study.接受重症监护或加强护理的 COVID-19 感染患者的护理和临床结局：一项多中心、前瞻性、观察性队列研究。

Lancet. 2021 May 22;397(10288):1885-1894. doi: 10.1016/S0140-6736(21)00441-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验